vs
自然阳光（NATR）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
自然阳光的季度营收约是REPUBLIC BANCORP INC的1.3倍（$123.8M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs 3.3%，领先20.9%），REPUBLIC BANCORP INC同比增速更快（5.3% vs 4.7%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $7.6M），过去两年自然阳光的营收复合增速更高（5.6% vs -11.5%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
NATR vs RBCAA — 直观对比
营收规模更大
NATR
是对方的1.3倍
$94.3M
营收增速更快
RBCAA
高出0.6%
4.7%
净利率更高
RBCAA
高出20.9%
3.3%
自由现金流更多
RBCAA
多$153.5M
$7.6M
两年增速更快
NATR
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $94.3M |
| 净利润 | $4.1M | $22.8M |
| 毛利率 | 72.5% | — |
| 营业利润率 | 4.3% | 29.3% |
| 净利率 | 3.3% | 24.2% |
| 营收同比 | 4.7% | 5.3% |
| 净利润同比 | 1379.4% | 20.0% |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRRBCAA
| Q4 25 | $123.8M | $94.3M | ||
| Q3 25 | $128.3M | $93.5M | ||
| Q2 25 | $114.8M | $93.8M | ||
| Q1 25 | $113.2M | $135.8M | ||
| Q4 24 | $118.2M | $89.5M | ||
| Q3 24 | $114.6M | $88.1M | ||
| Q2 24 | $110.6M | $86.9M | ||
| Q1 24 | $111.0M | $120.3M |
净利润NATRRBCAA
| Q4 25 | $4.1M | $22.8M | ||
| Q3 25 | $5.3M | $29.7M | ||
| Q2 25 | $5.3M | $31.5M | ||
| Q1 25 | $4.7M | $47.3M | ||
| Q4 24 | $-321.0K | $19.0M | ||
| Q3 24 | $4.3M | $26.5M | ||
| Q2 24 | $1.3M | $25.2M | ||
| Q1 24 | $2.3M | $30.6M |
毛利率NATRRBCAA
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
营业利润率NATRRBCAA
| Q4 25 | 4.3% | 29.3% | ||
| Q3 25 | 7.0% | 40.4% | ||
| Q2 25 | 3.7% | 43.0% | ||
| Q1 25 | 5.4% | 44.1% | ||
| Q4 24 | 3.8% | 25.8% | ||
| Q3 24 | 4.6% | 38.4% | ||
| Q2 24 | 5.1% | 37.0% | ||
| Q1 24 | 4.2% | 32.2% |
净利率NATRRBCAA
| Q4 25 | 3.3% | 24.2% | ||
| Q3 25 | 4.2% | 31.8% | ||
| Q2 25 | 4.6% | 33.5% | ||
| Q1 25 | 4.2% | 34.8% | ||
| Q4 24 | -0.3% | 21.2% | ||
| Q3 24 | 3.8% | 30.1% | ||
| Q2 24 | 1.2% | 29.0% | ||
| Q1 24 | 2.1% | 25.4% |
每股收益（稀释后）NATRRBCAA
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.25 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $161.6M | $1.1B |
| 总资产 | $261.1M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NATRRBCAA
| Q4 25 | $93.9M | $220.0M | ||
| Q3 25 | $95.6M | $484.2M | ||
| Q2 25 | $81.3M | $484.8M | ||
| Q1 25 | $86.5M | $793.0M | ||
| Q4 24 | $84.7M | $432.2M | ||
| Q3 24 | $78.7M | $530.9M | ||
| Q2 24 | $68.7M | $400.1M | ||
| Q1 24 | $77.8M | $546.4M |
总债务NATRRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRRBCAA
| Q4 25 | $161.6M | $1.1B | ||
| Q3 25 | $166.7M | $1.1B | ||
| Q2 25 | $163.7M | $1.1B | ||
| Q1 25 | $167.1M | $1.0B | ||
| Q4 24 | $161.0M | $992.0M | ||
| Q3 24 | $162.6M | $979.7M | ||
| Q2 24 | $156.4M | $955.4M | ||
| Q1 24 | $159.7M | $935.6M |
总资产NATRRBCAA
| Q4 25 | $261.1M | $7.0B | ||
| Q3 25 | $264.8M | $7.0B | ||
| Q2 25 | $254.9M | $7.0B | ||
| Q1 25 | $252.7M | $7.1B | ||
| Q4 24 | $240.9M | $6.8B | ||
| Q3 24 | $245.3M | $6.7B | ||
| Q2 24 | $235.8M | $6.6B | ||
| Q1 24 | $247.3M | $6.9B |
负债/权益比NATRRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $161.1M |
| 自由现金流率自由现金流/营收 | 6.1% | 170.9% |
| 资本支出强度资本支出/营收 | 1.9% | 7.5% |
| 现金转化率经营现金流/净利润 | 2.41× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $28.8M | $288.6M |
8季度趋势，按日历期对齐
经营现金流NATRRBCAA
| Q4 25 | $9.9M | $168.2M | ||
| Q3 25 | $18.5M | $33.3M | ||
| Q2 25 | $4.3M | $8.4M | ||
| Q1 25 | $2.6M | $93.2M | ||
| Q4 24 | $12.2M | $149.0M | ||
| Q3 24 | $9.6M | $51.3M | ||
| Q2 24 | $1.3M | $4.0M | ||
| Q1 24 | $2.2M | $71.2M |
自由现金流NATRRBCAA
| Q4 25 | $7.6M | $161.1M | ||
| Q3 25 | $16.8M | $30.8M | ||
| Q2 25 | $3.0M | $5.2M | ||
| Q1 25 | $1.5M | $91.6M | ||
| Q4 24 | $10.0M | $143.2M | ||
| Q3 24 | $7.9M | $49.8M | ||
| Q2 24 | $-2.0M | $2.7M | ||
| Q1 24 | $-1.5M | $69.1M |
自由现金流率NATRRBCAA
| Q4 25 | 6.1% | 170.9% | ||
| Q3 25 | 13.1% | 32.9% | ||
| Q2 25 | 2.6% | 5.5% | ||
| Q1 25 | 1.3% | 67.4% | ||
| Q4 24 | 8.5% | 160.0% | ||
| Q3 24 | 6.9% | 56.5% | ||
| Q2 24 | -1.9% | 3.1% | ||
| Q1 24 | -1.4% | 57.5% |
资本支出强度NATRRBCAA
| Q4 25 | 1.9% | 7.5% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.2% | 3.5% | ||
| Q1 25 | 1.0% | 1.2% | ||
| Q4 24 | 1.9% | 6.5% | ||
| Q3 24 | 1.5% | 1.7% | ||
| Q2 24 | 3.0% | 1.5% | ||
| Q1 24 | 3.3% | 1.7% |
现金转化率NATRRBCAA
| Q4 25 | 2.41× | 7.37× | ||
| Q3 25 | 3.46× | 1.12× | ||
| Q2 25 | 0.81× | 0.27× | ||
| Q1 25 | 0.55× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | 2.21× | 1.93× | ||
| Q2 24 | 0.97× | 0.16× | ||
| Q1 24 | 0.94× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RBCAA
暂无分部数据
